These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36296228)

  • 1. First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco.
    Colson P; Lavagna C; Delerce J; Groshenry G; Yahi N; Fantini J; La Scola B; Althaus T
    Microorganisms; 2022 Sep; 10(10):. PubMed ID: 36296228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia.
    Almalki SSR; Izhari MA; Alyahyawi HE; Alatawi SK; Klufah F; Ahmed WAM; Alharbi R
    J Multidiscip Healthc; 2023; 16():2117-2136. PubMed ID: 37529147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Co-Infections and Recombinations Identified by Long-Read Single-Molecule Real-Time Sequencing.
    Trémeaux P; Latour J; Ranger N; Ferrer V; Harter A; Carcenac R; Boyer P; Demmou S; Nicot F; Raymond S; Izopet J
    Microbiol Spectr; 2023 Aug; 11(4):e0049323. PubMed ID: 37260377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational characterization of Omicron SARS-CoV-2 lineages circulating in Chhattisgarh, a central state of India.
    Singh P; Sharma K; Shaw D; Bhargava A; Negi SS
    Front Med (Lausanne); 2022; 9():1082846. PubMed ID: 36755883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First cases of infection with the 21L/BA.2 Omicron variant in Marseille, France.
    Colson P; Delerce J; Beye M; Levasseur A; Boschi C; Houhamdi L; Tissot-Dupont H; Yahi N; Million M; La Scola B; Fantini J; Raoult D; Fournier PE
    J Med Virol; 2022 Jul; 94(7):3421-3430. PubMed ID: 35243660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
    J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants.
    Roe TL; Brady T; Schuko N; Nguyen A; Beloor J; Guest JD; Aksyuk AA; Tuffy KM; Zhang T; Streicher K; Kelly EJ; Kijak GH
    Microbiol Spectr; 2023 Mar; 11(2):e0033323. PubMed ID: 36877050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 21L/BA.2-21K/BA.1 "MixOmicron" SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis.
    Colson P; Delerce J; Marion-Paris E; Lagier JC; Levasseur A; Fournier PE; La Scola B; Raoult D
    Infect Genet Evol; 2022 Nov; 105():105360. PubMed ID: 36070806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearance of Imported Cases of Omicron Lineage BA.2.40 in West Kalimantan, Indonesia.
    Liana DF; Novianry V; Andriani A; Mahyarudin M; Astuti P
    Iran J Med Sci; 2024 Mar; 49(3):176-185. PubMed ID: 38584647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.
    Medits I; Springer DN; Graninger M; Camp JV; Höltl E; Aberle SW; Traugott MT; Hoepler W; Deutsch J; Lammel O; Borsodi C; Puchhammer-Stöckl E; Zoufaly A; Weseslindtner L; Aberle JH; Stiasny K
    Front Immunol; 2022; 13():946318. PubMed ID: 35928813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Analysis of Conformational Dynamics and Systematic Characterization of Cryptic Pockets in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB.1 Spike Complexes with the ACE2 Host Receptor: Confluence of Binding and Structural Plasticity in Mediating Networks of Conserved Allosteric Sites.
    Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AlphaFold2-Enabled Atomistic Modeling of Structure, Conformational Ensembles, and Binding Energetics of the SARS-CoV-2 Omicron BA.2.86 Spike Protein with ACE2 Host Receptor and Antibodies: Compensatory Functional Effects of Binding Hotspots in Modulating Mechanisms of Receptor Binding and Immune Escape.
    Raisinghani N; Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G
    J Chem Inf Model; 2024 Mar; 64(5):1657-1681. PubMed ID: 38373700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlocking the puzzle: non-defining mutations in SARS-CoV-2 proteome may affect vaccine effectiveness.
    Ulzurrun E; Grande-Pérez A; Del Hoyo D; Guevara C; Gil C; Sorzano CO; Campillo NE
    Front Public Health; 2024; 12():1386596. PubMed ID: 39228849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study.
    Zaballa ME; Perez-Saez J; de Mestral C; Pullen N; Lamour J; Turelli P; Raclot C; Baysson H; Pennacchio F; Villers J; Duc J; Richard V; Dumont R; Semaani C; Loizeau AJ; Graindorge C; Lorthe E; Balavoine JF; Pittet D; Schibler M; Vuilleumier N; Chappuis F; Kherad O; Azman AS; Posfay-Barbe KM; Kaiser L; Trono D; Stringhini S; Guessous I;
    Lancet Reg Health Eur; 2023 Jan; 24():100547. PubMed ID: 36474728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron.
    Wang L; Møhlenberg M; Wang P; Zhou H
    Cytokine Growth Factor Rev; 2023 Apr; 70():13-25. PubMed ID: 36948931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
    Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
    Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.
    da Silva ES; Kohnen M; Gilson G; Staub T; Arendt V; Hilger C; Servais JY; Charpentier E; Domingues O; Snoeck CJ; Ollert M; Seguin-Devaux C; Perez-Bercoff D
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome sequence diversity of SARS-CoV-2 in Serbia: insights gained from a 3-year pandemic study.
    Novkovic M; Banovic Djeri B; Ristivojevic B; Knezevic A; Jankovic M; Tanasic V; Radojicic V; Keckarevic D; Vidanovic D; Tesovic B; Skakic A; Tolinacki M; Moric I; Djordjevic V
    Front Microbiol; 2024; 15():1332276. PubMed ID: 38476954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring Conformational Landscapes and Cryptic Binding Pockets in Distinct Functional States of the SARS-CoV-2 Omicron BA.1 and BA.2 Trimers: Mutation-Induced Modulation of Protein Dynamics and Network-Guided Prediction of Variant-Specific Allosteric Binding Sites.
    Verkhivker G; Alshahrani M; Gupta G
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.